For years, the term “PCOS” — or polycystic ovary syndrome — has been one of the most misunderstood diagnoses in women’s health. Now, a new global consensus published in The Lancet proposes a significant and long-awaited change: renaming PCOS to Polyendocrine Metabolic Ovarian Syndrome (PMOS).

This shift is more than a name change. It represents a deeper understanding of the condition and acknowledges what many women have experienced for years: PCOS affects far more than the ovaries.

According to Teede H, Khomami M, Morman R, et al., the new name emerged from a large international consensus process involving thousands of patients, healthcare professionals, advocacy groups, and researchers worldwide.

Why the Name “PCOS” Has Been Problematic

The term polycystic ovary syndrome has long been criticized because many women with the condition do not actually have ovarian cysts. Instead, the condition is driven by a complex interaction of:

• Hormonal dysregulation
• Insulin resistance
• Metabolic dysfunction
• Inflammation
• Reproductive challenges
• Neuroendocrine abnormalities

The old name often caused:

• Delayed diagnosis
• Confusion among patients
• Stigma
• Fragmented care
• Under-recognition of metabolic risks

The proposed term Polyendocrine Metabolic Ovarian Syndrome (PMOS) better reflects the condition’s true multisystem nature.

What Does PMOS Mean?

The new name breaks down into three important components

Polyendocrine

Recognizes that multiple hormone systems are involved — not just the ovaries.

Metabolic

Highlights the strong connection to:

• Insulin resistance
• Weight changes
• Blood sugar dysregulation
• Cardiovascular risk
• Inflammation

Ovarian

Acknowledges reproductive and ovulatory dysfunction while avoiding the misleading “cyst” terminology.

The 5 Most Important Takeaways About the PMOS Name Change

1. PCOS Was Never Just About Ovarian Cysts

The condition affects the endocrine, metabolic, and reproductive systems simultaneously. Many women diagnosed with PCOS never had true ovarian cysts at all.

2. The New Name Reflects Whole-Body Health

PMOS better captures the links between hormones, metabolism, fertility, inflammation, mood, and long-term cardiovascular health.

3. Thousands of Patients and Professionals Helped Shape the Change

The consensus process involved more than 14,000 participants globally, including patients, physicians, advocacy groups, and researchers.

4. The Goal Is Better Diagnosis and Less Stigma

Researchers hope the new terminology will improve awareness, reduce confusion, and help women receive earlier and more comprehensive care.

5. The Transition Will Take Time

The rollout is expected to occur gradually over several years with updates to education, guidelines, research terminology, and healthcare systems worldwide.

What Are the Diagnostic Features of PMOS?

While the name is changing, the underlying diagnostic framework remains centered around the core clinical features already recognized in PCOS research.

PMOS is associated with:

• Hyperandrogenism (elevated androgens or symptoms like acne/hirsutism)
• Ovulatory dysfunction or irregular menstrual cycles
• Insulin resistance and metabolic dysfunction
• Ovarian dysfunction
• Fertility challenges
• Increased cardiometabolic risk

The article emphasizes that PMOS is a multisystem endocrine-metabolic condition, not solely a reproductive disorder.

Why Previous Efforts to Rename PCOS Failed

Earlier attempts to rename PCOS struggled because:

• No single replacement term gained broad agreement
• Some names increased stigma
• Certain terms did not translate well culturally or linguistically
• Stakeholders worried about confusion during transition
• Many proposed names failed to reflect the metabolic component of the condition

This new initiative succeeded because it used a rigorous, transparent global consensus process with extensive patient involvement and international collaboration.

A More Compassionate and Accurate Future for Women’s Health

For many women, this change feels validating.

Women living with PMOS often experience:

• Fatigue
• Anxiety
• Weight struggles
• Fertility concerns
• Mood changes
• Body image distress
• Insulin resistance
• Inflammation
• Hormonal imbalance

Yet historically, care has sometimes focused only on irregular cycles or fertility.

The transition to PMOS reflects a broader movement toward understanding women’s health through a more holistic, integrative lens — one that recognizes the connection between hormones, metabolism, nervous system regulation, mental health, and long-term wellness.

At Sage & Stone Holistic Counseling & Integrative Health, we believe women deserve care that sees the whole person — not just a diagnosis.

Citation & Link

Teede, H., Khomami, M., Morman, R., et al. (2026). Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: A multistep global consensus process. The Lancet, 0. 

Read Now